The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

Wake Forest University (WFU)

Status: Enrolling

Conditions: Acute Lymphocytic Leukemia; Multiple Myeloma; Acute Myelogenous Leukemia; Immunodeficiency Diseases; Non-Hodgkin's Lymphoma; Hodgkin's Disease; Chronic Myelogenous Leukemia; Chronic Lymphocytic Leukemia; Germ Cell Neoplasms; Myelodysplastic Syndromes

Study type: Observational

Funder types: Other

Identifiers

NCT01890486

CCCWFU 95300

Details and patient eligibility

About

To provide the IRB approved mechanism for the prospective collection, analysis and reporting of data on patients who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed and for which peer reviewed, published data have demonstrated efficacy for this treatment approach.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18 to 120 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant

Exclusion criteria

Participation in any other treatment research protocol